Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10905784 Radiolabeled anti-LAG3 antibodies for immuno-PET imaging

Patent 10905784 was granted and assigned to Regeneron Pharmaceuticals on February, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 12 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 12 Dec, 2023
Edits made to:
Article (+193 characters)
Article

Patent abstract

Radiolabeled anti-LAG3 antibodies and their use in immuno-PET imaging are provided herein. Included are methods of detecting the presence of LAG3 proteins in a patient or sample.

Edits on 5 Jul, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 5 Jul, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11692032 Anti-LAG3 antibodies and uses thereof
0
Edits on 22 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 22 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=1090578400
Edits on 24 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 24 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
0
Current Assignee
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
109057840
Date of Patent
February 2, 2021
0
Patent Application Number
158924400
Date Filed
February 9, 2018
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=109057840
Patent Citations Received
‌
US Patent 11511001 Radiolabeled anti-LAG3 antibodies for immuno-PET imaging
0
Patent Primary Examiner
‌
D. L. Jones
0
Edits on 1 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 1 Apr, 2023
Edits on 30 Nov, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 30 Nov, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11511001 Radiolabeled anti-LAG3 antibodies for immuno-PET imaging
0
Edits on 24 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 24 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
0
Current Assignee
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
109057840
Date of Patent
February 2, 2021
0
Patent Application Number
158924400
Date Filed
February 9, 2018
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=109057840
Patent Primary Examiner
‌
D. L. Jones
0
Edits on 17 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 17 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=10905784
Edits on 9 Feb, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 9 Feb, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 10905784 Radiolabeled anti-LAG3 antibodies for immuno-PET imaging

Infobox
Is a
Patent
Patent
Patent applicant
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Current assignee
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
10905784
Date of patent
February 2, 2021
Patent application number
15892440
Date Filed
February 9, 2018
Patent primary examiner
‌
D. L. Jones

Find more entities like US Patent 10905784 Radiolabeled anti-LAG3 antibodies for immuno-PET imaging

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo